T1	Participants 61 69	melanoma
T2	Participants 153 202	patients with positive sentinel lymph nodes (SLN)
T3	Participants 465 581	Patients with stage I/II melanoma, consecutively submitted to a SLN procedure by the same surgeon from 2000 to 2006,
T4	Participants 839 851	381 patients
